Showing 1 - 7 results of 7 for search 'Nicola Longo', query time: 0.01s
Refine Results
-
1
Granulomatous prostatitis mimicking prostate cancer in a patient with psoriatic arthritis: a case report by Luigi De Luca, Felice Crocetto, Biagio Barone, Massimiliano Creta, Salvatore Pesce, Achille Aveta, Maria Raffaela Campanino, Ciro Imbimbo, Nicola Longo
Published 2020-08-01Get full text
Article -
2
P030: Update from PHEFREE: The National Institutes of Health Rare Disease Consortium for Hyperphenylalaninemia by Georgianne Arnold, Hadley Morotti, Gerard Berry, Shawn Christ, Dorothy Grange, Cary Harding, Elaina Jurecki, Uta Lichter-Konecki, Harvey Levy, Nicola Longo, Stephanie Sacharow, Brian Shayota, Janet Thomas, Desiree White
Published 2025-01-01Get full text
Article -
3
Outcomes of Salvage Treatment After Primary Treatment for Renal Cell Cancer: A Systematic Review by Nicola Longo, Francesco Di Bello, Luigi Napolitano, Ernesto Di Mauro, Simone Morra, Giuliano Granata, Federico Polverino, Agostino Fraia, Gabriele Pezone, Roberto La Rocca, Claudia Collà Ruvolo, Gianluigi Califano, Massimiliano Creta
Published 2025-03-01Get full text
Article -
4
P047: Interim results from the APHENITY extension study: Sepiapterin reduces blood Phe with improved dietary Phe tolerance in participants with phenylketonuria by Nicola Longo, Francjan van Spronsen, Ania Muntau, Lali Margvelashvili, Heidi Peters, Ida Vanessa Schwartz, Takashi Hamazaki, Maria Avanise Yumi Minami, Laura Guilder, Drago Bratkovic, Melissa Lah, Janet Thomas, Frank Rutsch, Ertugrul Kiykim, Roberto Zori, Mika Ishige, Kimberly Ingalls, Catalina Hughes, Lan Gao, Zhenming Zhao, Neil Smith
Published 2025-01-01Get full text
Article -
5
P236: Extending the interval between pegunigalsidase alfa infusions in patients with Fabry disease: Five-year interim results from the ongoing BRIGHT51 study by John Bernat, Myrl Holida, Stephen Waldek, William Wilcox, Nicola Longo, Ozlem Goker-Alpan, Eric Wallace, Patrick Deegan, Camilla Tondel, François Eyskens, Ulla Feldt-Rasmussen, Derralynn Hughes, Antonio Pisani, Ankit Mehta, Khan Nedd, David Warnock, Giovanni Piotti, Meng Wang, Einat Almon-Brill, Sari Alon, Raul Chertkoff, Ales Linhart
Published 2025-01-01Get full text
Article -
6
Establishing a core outcome set for creatine transporter deficiency and guanidinoacetate methyltransferase deficiency by Zahra Nasseri Moghaddam, Emily K. Reinhardt, Audrey Thurm, Beth K. Potter, Maureen Smith, Celeste Graham, Beth H. Tiller, Steven A. Baker, Deborah A. Bilder, Regina Bogar, Jacobus Britz, Rachel Cafferty, Daniel P. Coller, Ton J. DeGrauw, Vicky Hall, Gerald S. Lipshutz, Nicola Longo, Saadet Mercimek-Andrews, Judith S. Miller, Marzia Pasquali, Gajja S. Salomons, Andreas Schulze, Celine P. Wheaton, Kayla F. Williams, Sarah P. Young, Jasmine Li, Sofia Balog, Theresa Selucky, Sylvia Stöckler-Ipsiroglu, Heidi Wallis
Published 2025-08-01Get full text
Article -
7
Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial by Amel Karaa, Enrico Bertini, Valerio Carelli, Bruce Cohen, Gregory M. Ennes, Marni J. Falk, Amy Goldstein, Gráinne Gorman, Richard Haas, Michio Hirano, Thomas Klopstock, Mary Kay Koenig, Cornelia Kornblum, Costanza Lamperti, Anna Lehman, Nicola Longo, Maria Judit Molnar, Sumit Parikh, Han Phan, Robert D. S. Pitceathly, Russekk Saneto, Fernando Scaglia, Serenella Servidei, Mark Tarnopolsky, Antonio Toscano, Johan L. K. Van Hove, John Vissing, Jerry Vockley, Jeffrey S. Finman, Anthony Abbruscato, David A. Brown, Alana Sullivan, James A. Shiffer, Michelango Mancuso, on behalf of the MMPOWER-3 Trial Investigators
Published 2024-11-01Get full text
Article